Stay updated on Delgocitinib Cream Dose-ranging Clinical Trial
Sign up to get notified when there's something new on the Delgocitinib Cream Dose-ranging Clinical Trial page.

Latest updates to the Delgocitinib Cream Dose-ranging Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe study record for the delgocitinib atopic dermatitis trial is now displayed, including its design, eligibility criteria, study locations, outcome measures, and record history.SummaryDifference62%

- Check15 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check22 days agoChange DetectedA banner announces an NIH transition notice about using “Super Intelligence” alongside “Artificial Intelligence” across NIH content.SummaryDifference1%

- Check28 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page.SummaryDifference0.2%

- Check35 days agoChange DetectedThe error page footer now lists site revision v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check56 days agoChange DetectedAccess to the study record is blocked by a 403 Forbidden error, replacing the usual study details with an error page. The screen shows a standard site header and a 403 message, indicating restricted access to the content.SummaryDifference18%

Stay in the know with updates to Delgocitinib Cream Dose-ranging Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Delgocitinib Cream Dose-ranging Clinical Trial page.